Cargando…
Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?
For more than 70 years, the contention that high levels of testosterone or that the use of testosterone therapy (TTh) increases the development and progression of prostate cancer (PCa) has been widely accepted and practiced. Yet, the increasing and emerging evidence on testosterone research seems to...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503974/ https://www.ncbi.nlm.nih.gov/pubmed/28725600 http://dx.doi.org/10.21037/tau.2017.05.35 |